Minding Research Ethics

The Presidential Commission for the Study of Bioethical Issues advises the integration of ethics into research on the human brain.

Written byTracy Vence
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

FLICKR, DIERK SCHAEFERIn its first of two reports on the subject, the Presidential Commission for the Study of Bioethical Issues today (May 14) responded to President Obama’s July request to consider the “rapidly emerging and evolving field of neuroscience.” While his administration’s Brain Research through Advancing Innovative Neurotechnologies (BRAIN) initiative, which is focused on mapping the human brain, motivated the review, in its analysis the Bioethics Commission considered neuroscience research more generally, and is now offering four recommendations focused on integrating ethics early on in modern neuroscience research. The commission stopped short of proposing research requirements, however.

“We have gone to great lengths to recommend [ethics] integration rather than regulation,” commission chair Amy Gutmann told reporters during a press conference Tuesday (May 13). But she added that with advances—and increasing public interest—in neuroimaging, deep-brain stimulation, and cognitive enhancement, among other things, now is the time to ensure that ethics are ingrained in the neuroscience research process. “Research on our brains strikes at the very core of who we are, so the ethical stakes . . . could not be higher.”

“We are truly on the threshold of making practical discoveries and advances that could provide enormous benefit but that also need to be assessed in terms of their appropriate use by all stakeholders,” added commission member Stephen Hauser. “The momentum and the ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies